(Q31130084)

18 August 2017

Genomic Grade Index (GGI): feasibility in routine practice and impact on treatment decisions in early breast cancer (English)

1 reference

18 August 2017

4

Marc Buyse

0 references

Evandro de Azambuja

7

object named as

Evandro de Azambuja

0 references

Stefan Michiels

object named as

Stefan Michiels

3

0 references

Peter Vuylsteke

20

object named as

Peter Vuylsteke

1 reference

18 August 2017

Otto Metzger-Filho

1

1 reference

18 August 2017

Aurélie Catteau

2

1 reference

18 August 2017

Michail Ignatiadis

5

1 reference

18 August 2017

Kamal S Saini

6

1 reference

18 August 2017

Virginie Fasolo

8

1 reference

18 August 2017

Sihem Naji

9

1 reference

18 August 2017

Jean Luc Canon

10

1 reference

18 August 2017

Paul Delrée

11

1 reference

18 August 2017

Michel Coibion

12

1 reference

18 August 2017

Pino Cusumano

13

1 reference

18 August 2017

Veronique Jossa

14

1 reference

18 August 2017

Jean Pierre Kains

15

1 reference

18 August 2017

Denis Larsimont

16

1 reference

18 August 2017

Vincent Richard

17

1 reference

18 August 2017

Daniel Faverly

18

1 reference

18 August 2017

Nathalie Cornez

19

1 reference

18 August 2017

Brigitte Vanderschueren

21

1 reference

18 August 2017

Hélène Peyro-Saint-Paul

22

1 reference

18 August 2017

Martine Piccart

23

1 reference

18 August 2017

Christos Sotiriou

24

1 reference

18 August 2017

language of work or name

English

0 references

publication date

19 August 2013

1 reference

18 August 2017

1 reference

18 August 2017

8

1 reference

18 August 2017

8

1 reference

18 August 2017

e66848

1 reference

Creative Commons Attribution 4.0 International

18 August 2017

start time

19 August 2013

1 reference

April 2022 Public Data File from Crossref

copyright status

copyrighted

0 references

cites work

Respective prognostic value of genomic grade and histological proliferation markers in early stage (pN0) breast carcinoma

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3747186

Targeting adjuvant chemotherapy: a good idea that needs to be proven!

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3747186

Genomic Grade Index: An important tool for assessing breast cancer tumor grade and prognosis

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3747186

Prospective multicenter study of the impact of the 21-gene recurrence score assay on medical oncologist and patient adjuvant breast cancer treatment selection

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3747186

Prognostic and predictive value of the 21-gene recurrence score assay in postmenopausal women with node-positive, oestrogen-receptor-positive breast cancer on chemotherapy: a retrospective analysis of a randomised trial

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3747186

Thresholds for therapies: highlights of the St Gallen International Expert Consensus on the primary therapy of early breast cancer 2009

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3747186

Genomic grade index is associated with response to chemotherapy in patients with breast cancer

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3747186

Gene-expression signatures in breast cancer

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3747186

Clinical application of the 70-gene profile: the MINDACT trial

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3747186

Development of the 21-gene assay and its application in clinical practice and clinical trials

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3747186

Use of 70-gene signature to predict prognosis of patients with node-negative breast cancer: a prospective community-based feasibility study (RASTER).

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3747186

American Society of Clinical Oncology 2007 update of recommendations for the use of tumor markers in breast cancer

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3747186

Definition of clinically distinct molecular subtypes in estrogen receptor-positive breast carcinomas through genomic grade

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3747186

Gene expression and benefit of chemotherapy in women with node-negative, estrogen receptor-positive breast cancer

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3747186

Gene expression profiling in breast cancer: understanding the molecular basis of histologic grade to improve prognosis

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3747186

A multigene assay to predict recurrence of tamoxifen-treated, node-negative breast cancer

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3747186

A gene-expression signature as a predictor of survival in breast cancer

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3747186

Genomic grade adds prognostic value in invasive lobular carcinoma.

21 June 2018

1 reference

Crossref

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0066848

Gene modules and response to neoadjuvant chemotherapy in breast cancer subtypes: a pooled analysis.

21 January 2018

1 reference

Crossref

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0066848

Daily clinical practice of fresh tumour tissue freezing and gene expression profiling; logistics pilot study preceding the MINDACT trial.

21 January 2018

1 reference

Crossref

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0066848

10.1371/JOURNAL.PONE.0066848

21 January 2018

Identifiers

DOI

1 reference

18 August 2017

0 references

1 reference

18 August 2017

PubMed publication ID

23990869

1 reference